All lobbying filings
Talley Strategies LLC
Talley Strategies LLC filed a Q3 termination report for Teva Pharmaceuticals USA, Inc. on September 4, 2026, reporting no lobbying activity.
Lobbying for Teva Pharmaceuticals USA, Inc. · Pharmaceutical company
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Sep 4, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Representation ended
Aug 31, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.